Amount of Proteinuria and Duration of Expectant Management in Severe Preeclampsia

被引:0
|
作者
Cozzi, Gabriella D. [1 ,2 ]
Battarbee, Ashley N. [1 ,2 ]
Sanjanwala, Aalok R. [1 ,2 ]
Casey, Brian M. [1 ,2 ]
Subramaniam, Akila [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Ctr Womens Reprod Hlth, Dept Obstet & Gynecol, Birmingham, AL 35249 USA
[2] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35249 USA
关键词
cesarean delivery; hypoxic ischemic encephalopathy; maternal death; intensive care unit; massive proteinuria; placental abruption; pulmonary edema; LINKING PLACENTAL ISCHEMIA; HYPERTENSIVE DISORDERS; PERINATAL OUTCOMES; PREGNANCY; PATHOPHYSIOLOGY; DIAGNOSIS; FETAL;
D O I
10.1055/s-0042-1748524
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The aim of the study is to evaluate the association between the amount of proteinuria at the time of diagnosis of preeclampsia with severe features (severe preeclampsia [SPE]) and duration of expectant management (EM) and other perinatal outcomes. Study Design This is a retrospective cohort study of patients with SPE delivering live, non-anomalous singletons at 23 (0/7) to 34 (2/7) weeks' estimated gestational age (EGA) at a single tertiary center 2016 to 2018. Patients with proteinuria assessment (24-hour total urine protein or urine protein-to-creatinine ratio extrapolation) within 3 days of SPE diagnosis were included. Patients delivered for an indication other than SPE were excluded. Patients were categorized by amount of proteinuria (mg): none (<= 300), mild (301-1,000), moderate (1,001-3,000), and massive (>= 3,001). The primary outcome was the proportion of potential EM time achieved (%EM), i.e., days of EM divided by days from SPE diagnosis to 34 weeks. Secondary outcomes included delivery EGA, days of EM, and perinatal outcomes. Bivariable and multivariable analyses compared outcomes across groups. Results Of 295 patients included, 21% had no proteinuria, 33% mild, 19% moderate, and 27% massive. Groups differed by EGA at diagnosis, age, parity, chronic hypertension, and renal disease. %EM was not significantly different between groups (adjusted beta coefficient 4.1 [95% CI -5.3, 13.5] for mild proteinuria vs. none, -4.1 [95% CI -14.9, 6.6] for moderate proteinuria vs. none, and -5.6 [95% CI -16.0, 4.7] for massive proteinuria vs. none). Increasing proteinuria was associated with earlier delivery EGA but only days of EM in the mild versus no proteinuria groups. There was no significant association between proteinuria and maternal composite morbidity, but patients with mild and massive proteinuria had higher odds of neonatal composite morbidities compared with no proteinuria. Conclusion Among patients with SPE, proteinuria level was not consistently associated with duration of EM. However, patients with the greatest amounts of proteinuria may have worse neonatal and selected maternal outcomes.
引用
收藏
页码:790 / 797
页数:8
相关论文
共 50 条
  • [31] Expectant management of severe preeclampsia remote from term: patient selection, management, and delivery indications
    Sibai, Baba M.
    Barton, John R.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (06) : 514 - 516
  • [32] Proteinuria in severe preeclampsia: Is it still relevant?
    Murali, Akshaya
    Rengaraj, Sasirekha
    Priyamvada, P. S.
    Sivanandan, Sindhu
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 : 29 - 29
  • [33] Expectant management of mild preeclampsia REPLY
    Valent, Amy M.
    DeFranco, Emily A.
    Sibai, Baha M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (05) : 750 - 751
  • [34] Expectant management of severe preterm preeclampsia: Is intrauterine growth restriction an indication for immediate delivery?
    Chammas, MF
    Nguyen, TM
    Li, MA
    Nuwayhid, BS
    Castro, LC
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (04) : 853 - 858
  • [35] Expectant management of severe preeclampsia remote from term: hope for the best, but expect the worst
    Norwitz, Errol R.
    Funai, Edmund F.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (03) : 209 - 212
  • [36] Expectant Management of Severe Preeclampsia in Pregnancies <32 Weeks Does Not Improve Neonatal Outcomes
    Oxford, Corrina
    Abbasi, Soraya
    Fisher, Lytia
    Mottola, Christina
    Ludmir, Jack
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 308A - 308A
  • [37] Discussion: 'Expectant management of severe preeclampsia,' by Vigil-De Gracia et al
    Carter, Ebony Boyce
    Macones, George A.
    Theilen, Lauren
    Fjeldstad, Heidi
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 209 (05) : E1 - E3
  • [38] Do ACOG criteria for expectant management predict maternal morbidity in women with severe preeclampsia?
    Sinkey, Rachel
    Jauk, Victoria C.
    Sanjanwala, Aalok R.
    Cozzi, Gabriella D.
    Becker, David A.
    Harper, Lorie M.
    Casey, Brian M.
    Subramaniam, Akila
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S104 - S104
  • [39] EXPECTANT MANAGEMENT IN SEVERE PREECLAMPSIA - DOES MAGNESIUM-SULFATE PREVENT THE DEVELOPMENT OF ECLAMPSIA
    CHEN, FP
    CHANG, SD
    CHU, KK
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1995, 74 (03) : 181 - 185
  • [40] Expectant versus aggressive management of severe preeclampsia at 24-34 weeks of gestation
    Ghazali, Sarah M.
    AlGhamdi, Ohoud A.
    Sahly, Nora N.
    Nagadi, Kholoud K.
    Khalifah, Reem M.
    Hanbazaza, Sedrah M.
    Krimli, Danah I.
    Allaf, Sarah M.
    Turkistani, Renad A.
    Mansouri, Haifa'a A.
    MEDICAL SCIENCE, 2022, 26 (130)